Business Context and Reporting Period
Pediatrix Medical Group, Inc. filed its Form 10-Q for the quarterly period ended June 30, 1997. The Company operates neonatal intensive care units (NICUs) and physician group practices. During the first six months of 1997, the Company aggressively expanded through the acquisition of six physician group practices and the addition of three internal NICUs, totaling 14 new units.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1997 | Six Months Ended June 30, 1996 |
|---|---|---|
| Net Patient Service Revenue | $57,612,000 | $33,935,000 |
| Net Income | $9,076,000 | $5,647,000 |
| Diluted EPS | $0.58 | $0.41 |
| Operating Cash Flow | $8,755,000 | $3,960,000 |
| Cash and Cash Equivalents (End of Period) | $27,369,000 | $10,077,000 |
| Total Assets | $173,765,000 | $159,026,000 |
| Total Liabilities | $24,192,000 | $22,705,000 |
| Working Capital | $66,955,000 | $81,187,000 |
Margins: Net income as a percentage of net patient service revenue was 15.8% for the six months ended June 30, 1997, compared to 16.6% in the prior year period.
Material Changes vs. Prior Period
- Revenue Growth: Net patient service revenue increased 69.8% year-over-year. Approximately 96.9% of the revenue increase in the second quarter was attributable to new units acquired or added.
- Expense Increases: Salaries and benefits rose 67.4% to $37.4 million, driven primarily by hiring new physicians for new units. Depreciation and amortization increased 215.3% to $1.8 million due to goodwill amortization from acquisitions.
- Profitability: Net income increased 60.7% to $9.1 million. However, net income margins compressed slightly due to the amortization of goodwill associated with recent acquisitions.
- Liquidity: Working capital decreased by $14.2 million to $67.0 million, primarily due to cash utilized for acquisitions ($27 million paid in the first six months), partially offset by strong operating cash flow.
Guidance, Outlook, and Risks
Outlook: Management anticipates that funds generated from operations, existing cash, marketable securities, and available credit facilities will be sufficient to meet working capital requirements and finance capital expenditures for at least the next twelve months. Capital expenditures for the remainder of 1997 are projected at approximately $1.0 million.
Risks and Contingencies:
- IRS Examination: The Company is under examination for tax years 1992-1994. The IRS has challenged deductions that could result in additional taxes of approximately $4.5 million plus interest. Management believes the returns are correct and intends to contest the adjustments.
- Contract Dispute: A hospital customer disputes a contract interpretation, seeking a refund of approximately $7.5 million in payments made over the last five years. Management disagrees with the claim and expects an amicable resolution, though litigation is possible.
- Legal Proceedings: The Company faces pending medical malpractice claims, which are generally covered by insurance. Management does not expect a material adverse effect.
Subsequent Events: Following June 30, 1997, the Company completed two additional acquisitions for approximately $20 million in cash.
Investor Verification Checklist
- Verify the sustainability of revenue growth from acquisitions versus organic same-unit growth (reported as only 1.1% for the six-month period).
- Monitor the resolution of the $7.5 million contract dispute with the hospital customer.
- Track the outcome of the IRS examination regarding the potential $4.5 million tax liability.
- Assess the impact of goodwill amortization on future net income margins as the acquisition pipeline continues.
- Confirm the Company's ability to fund future acquisitions without diluting shareholders, given the recent cash outflows.